Loading...
•
Mar 31, 2023
Select Medical Q1 2023 Earnings Report
Select Medical's financial performance improved in Q1 2023 with revenue and net income increasing.
Key Takeaways
Select Medical Holdings Corporation reported a 4.1% increase in revenue to $1,665.0 million for the first quarter ended March 31, 2023, compared to $1,599.5 million for the same quarter prior year. Net income increased 52.4% to $85.3 million, compared to $55.9 million for the same quarter, prior year.
Revenue increased by 4.1% to $1,665.0 million compared to the same quarter last year.
Net income increased by 52.4% to $85.3 million compared to the same quarter last year.
Earnings per common share increased 51.3% to $0.56 compared to the same quarter last year.
The Board of Directors declared a cash dividend of $0.125 per share.
Select Medical
Select Medical
Select Medical Revenue by Segment
Revenue by Segment
Critical Illness Recovery Hospital Revenue
CapyFin.comRehabilitation Hospital Revenue
CapyFin.comOutpatient Rehabilitation Revenue
CapyFin.com Forward Guidance
Select Medical reaffirms its 2023 business outlook for revenue, expecting consolidated revenue to be in the range of $6.5 billion to $6.7 billion. The company also expects Adjusted EBITDA to be in the range of $780.0 million to $820.0 million and fully diluted earnings per common share to be in the range of $1.75 to $1.99.
Revenue & Expenses
Visualization of income flow from segment revenue to net income